+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type
6.1. Overview
6.2. Tablets
6.3. Nail Paints
7. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Route of Administration
7.1. Overview
7.2. Oral
7.3. Topical
8. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Type
8.1. Overview
8.2. Prescribed
8.3. Over-the-Counter (OTC)
9. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY End User
9.1. Overview
9.2. Hospitals & Clinics
9.3. Retail Pharmacies
9.4. Online Channels
10. GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, by Region
10.1. Overview
10.2. North America
10.2.1. US
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. UK
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. Competitive Landscape
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Dermatophytic Onychomycosis Treatment Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Dermatophytic Onychomycosis Treatment Market,
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. Company ProfileS
12.1. BAUSCH HEALTH COMPANIES INC.
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Pfizer Inc.
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Galderma
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. GlaxoSmithKline plc
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Janssen Pharmaceuticals, Inc.
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. CIPLA INC.
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Kaken pharmaceuticals Co., Ltd.
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
13. Appendix
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 Global Dermatophytic Onychomycosis Treatment Market, Synopsis, 2018-2032
TABLE 2 Global Dermatophytic Onychomycosis Treatment Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 4 North America: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 5 US: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 6 US: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Route of Administration, 2018-2032 (USD BILLION)
TABLE 7 US: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY End Use, 2018-2032 (USD BILLION)
TABLE 8 Canada: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 1 Europe: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 2 germany: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 3 FRANCE: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 4 italy: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 5 spain: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 6 UK: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 7 rest of europe: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 8 Asia-Pacific: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 9 japan: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 10 china: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 11 india: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 12 australia: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 13 south korea: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 14 rest of asia-pacific: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 15 rest of the world: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 16 Middle east: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 17 Africa: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
TABLE 18 Latin america: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, BY Product Type, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Dermatophytic Onychomycosis Treatment Market
FIGURE 3 Market Dynamics for the Global Dermatophytic Onychomycosis Treatment Market
FIGURE 4 Global Dermatophytic Onychomycosis Treatment Market, Share (%), BY Product Type, 2022
FIGURE 5 Global Dermatophytic Onychomycosis Treatment Market, Share (%), by Region, 2022
FIGURE 6 north AMERICA: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 7 Europe: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 Asia-Pacific: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Rest of the world: DERMATOPHYTIC ONYCHOMYCOSIS TREATMENT MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Global Dermatophytic Onychomycosis Treatment Market: Company Share Analysis, 2022 (%)
FIGURE 11 BAUSCH HEALTH COMPANIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 12 BAUSCH HEALTH COMPANIES INC.: SWOT ANALYSIS
FIGURE 13 Pfizer Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 Pfizer Inc.: SWOT ANALYSIS
FIGURE 15 Galderma: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 Galderma: SWOT ANALYSIS
FIGURE 17 GlaxoSmithKline plc: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 GlaxoSmithKline plc: SWOT ANALYSIS
FIGURE 19 Janssen Pharmaceuticals, Inc..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 Janssen Pharmaceuticals, Inc..: SWOT ANALYSIS
FIGURE 21 CIPLA INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 CIPLA INC.: SWOT ANALYSIS
FIGURE 23 Kaken pharmaceuticals Co., Ltd.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 Kaken pharmaceuticals Co., Ltd.: SWOT ANALYSIS
FIGURE 25 General Electric: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 General Electric: SWOT ANALYSIS
FIGURE 27 Koninklijke Philips N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 Koninklijke Philips N.V.: SWOT ANALYSIS
FIGURE 29 Carestream Health: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 Carestream Health: SWOT ANALYSIS
Report Code :
RL65115
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst